Health Canada has issued a Notice of Intent regarding Health Canada’s position on the classification of topical products containing human-derived exosomes, extracellular vesicles, and/or human cell-conditioned media. While the […]
PRODUCT LICENSING: There are approximately 4130 files in Class III (3980 in August) (this includes new and post-licensing files that are in queue and working), of those approximately […]
Federal Plastics Registry – Phase 1 Reporting Deadline – September 29, 2025 We want to remind members of the upcoming September 29, 2025, deadline for Phase 1 reporting under […]
Letter to the Prime Minster – CA Asks to Enhance Trade Competitiveness Aug 8 2025 This letter was recently sent by CA President Darren Praznik to Prime Minister Mark Carney. […]
On August 7, 2025, Environment and Climate Change Canada informed stakeholders that the lists in the Substance Search tool will now be updated on a weekly or bi-weekly basis. […]
The following summarizes four final opinions from the Scientific Committee on Consumer Safety (SCCS) published in late June and early July 2025. Hydroxyapatite (Nano): The SCCS concluded that a […]
The Court of Justice of the European Union has dismissed appeals from France and the European Commission, upholding a previous judgment that annulled the classification of titanium dioxide as […]
On August 1, 2025, Health Canada updated its Guidance on nitrosamine impurities in medications. The revised guidance includes several key changes: Timelines for Corrective Actions: Manufacturers have up to […]
There has been an official correction of a long-standing error in the English version of the Volatile Organic Compound (VOC) Concentration Limits for Certain Products Regulations. This error was […]
PRODUCT LICENSING: There are approximately 3980 files in Class III (3712 in June) (this includes new and post-licensing files that are in queue and working), of those approximately […]
